🔎 Today’s Daily Sift: Longevity The longevity industry is entering a new phase. What started as a biotech moonshot is becoming infrastructure. The strongest signals today suggest healthspan is evolving into a service, an investment category, and a lifestyle layer. Macro Forces Luxury residential projects are beginning to integrate longevity clinics, diagnostics, and preventive health programs directly into where people live. Aging is increasingly being viewed as something that can be measured, monitored, and optimized. Scientific Breakthroughs New research continues to expand the potential of GLP 1 therapies beyond weight loss, with evidence pointing toward broader metabolic and behavioral benefits. Researchers also reported advances in therapies that enhance muscle metabolism and discoveries of brain circuits linked to anxiety and resilience. The common theme is clear: medicine is moving toward managing biological systems rather than treating isolated symptoms. Capital Flo...